OTCMKTS:INIS

International Isotopes Stock News

etoro logo Buy INIS
*Your capital is at risk
$0.0700
-0.0027 (-3.71%)
At Close: Jun 22, 2026
IDAHO FALLS, Idaho, May 21, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company"), a manufacturer of radioisotope-focused products fo
IDAHO FALLS, Idaho, April 1, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company"), a leading manufacturer of radioisotope-focused te
International Isotopes Inc. (OTCMKTS:INIS - Get Free Report)'s share price passed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $
International Isotopes Inc. (OTCMKTS:INIS - Get Free Report)'s stock price passed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $0.07 and traded a
International Isotopes Inc. (OTCMKTS:INIS - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of
Shares of International Isotopes Inc. (OTCMKTS:INIS - Get Free Report) crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.07 and traded as
IDAHO FALLS, Idaho, Dec. 31, 2025 /PRNewswire/ -- International Isotopes Inc. ("INIS" or the "Company") (OTCQB:INIS) today announced that it has filed a Certificate of Amendment in the State of Texas
IDAHO FALLS, Idaho , Nov. 14, 2025 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") is pleased to announce its financial results for the third quarter and nine month
International Assets Investment Management LLC lowered its position in shares of Alphabet Inc. (NASDAQ: GOOGL) by 3.4% in the second quarter, according to the company in its most recent disclosure wit
Sale of product for the first six months of 2025 increased 13.5% or $820,529  Net Income (Loss) the first six months of 2025 improved 29% to a loss of $273,479 Non-GAAP EBITDA(1) the first six months
Sale of product for first quarter increased 12% to $3.2 million. Nuclear Medicine Standards sale of product in the first quarter increased 73% to $1.3 million.
Revenues for fourth quarter increased 24% to $3.9 million. Full year revenues increased by 13% to $13.9 million, a historical high.
IDAHO FALLS, Idaho , Jan. 13, 2025 /PRNewswire/ -- International Isotopes, Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company"), is excited to announce a strategic expansion of its c
IDAHO FALLS, Idaho , Jan. 9, 2025 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company") is pleased to announce that it has amended and final
Company Revenues increased by over $1,000,000, or 34%, for the Third Quarter compared to the prior year Theranostics Sales increased 42% compared the Third Quarter in the prior year The Company report
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE